Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase NA 25Phase 1 17Phase 1/2 11Phase 3 6Phase 2/3 4Phase EARLY_PHASE1 2Phase 4 1

Status

Withdrawn 2Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Multiple Myeloma 28Breast Neoplasms 23Neoplasms 21Pancreatic Neoplasms 17Glioma 17Prostatic Neoplasms 16Glioblastoma 16Recurrence 14Leukemia, Myeloid, Acute 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Melanoma 8Lymphoma 8Hematologic Neoplasms 8Lymphoma, B-Cell 7Colorectal Neoplasms 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Advanced Solid Tumors 6Sarcoma 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Cholangiocarcinoma × Clear all
NCT06406816 2025-05-15

Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection

Meng Chao Hepatobiliary Hospital of Fujian Medical University

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT06583993 2025-04-24

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Recruiting
9 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡